62 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
Dr. Reddy's Laboratories (RDY) Jumped After Court Ruling http://www.rttnews.com/story.aspx?Id=2810917 Sep 04, 2017 - A U.S. District Court ruled that Dr. Reddy's Laboratories (RDY) has not infringed on Indivior's patents for an opioid addiction treatment. Indivior plans to appeal the decision.
3 Top Generic Drug Stocks to Consider Buying Now https://www.fool.com/investing/2017/12/20/3-top-generic-drug-stocks-to-consider-buying-now.aspx?source=iedfolrf0000001 Dec 20, 2017 - Want to cash in on the pharmaceutical boom? Generic drugs add to the arguments for giving Pfizer, Novartis and Mylan a closer look.
Dr. Reddy's Laboratories' (RDY) Management on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4140207-dr-reddys-laboratories-rdy-management-q3-2018-results-earnings-call-transcript?source=feed_tag_india Jan 25, 2018 - Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) Q3 2018 Earnings Conference Call January 25, 2018 8:00 AM ET Executives Saunak Savla – Head-Investor Relations Saumen Chakraborty – President, Chief Financial
3 Things You'll Want to Know From Celgene's 1st Public Event After the Ozanimod Debacle https://www.fool.com/investing/2018/03/14/3-things-youll-want-to-know-from-celgenes-1st-publ.aspx?source=iedfolrf0000001 Mar 14, 2018 - The biotech's CFO talks about the future for ozanimod, challenges to Revlimid, and more at the Barclays healthcare conference.
Dr. Reddy's Laboratories Limited (RDY) Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4237615-dr-reddys-laboratories-limited-rdy-q3-2019-results-earnings-call-transcript?source=feed_tag_india Feb 01, 2019 -
Dr. Reddy's Laboratories Ltd (RDY) CEO Gunupati Prasad on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4264996-dr-reddys-laboratories-ltd-rdy-ceo-gunupati-prasad-q4-2019-results-earnings-call-transcript?source=feed_tag_india May 17, 2019 - Dr. Reddy's Laboratories Ltd (NYSE:RDY) Q4 2019 Earnings Conference Call May 17, 2019, 08:30 ET Company Participants Amit Agarwal - Director, Finance, FP&A & IR Gunupati Prasad - CEO Saumen Ch
Strength Seen in Mallinckrodt (MNK): Stock Rises 9.1% http://www.zacks.com/stock/news/187965/shares-of-mallinckrodt-mnk-rose-just-over-9-in-the-last-session?cid=CS-ZC-FT-187965 Aug 27, 2015 - Mallinckrodt (MNK) was a big mover last session, with shares rising just over 9% on the day.
Allergan Buys Naurex, Boosts Mental Health Portfolio http://www.zacks.com/stock/news/188559/allergan-buys-naurex-boosts-mental-health-portfolio?cid=CS-ZC-FT-188559 Sep 01, 2015 - Allergan (AGN) acquires central nervous system focused company, Naurex, to boost mental disorder portfolio.
Impax Hayward Facility Gets FDA Clearance, Shares Rise http://www.zacks.com/stock/news/189499/impax-hayward-facility-gets-fda-clearance-shares-rise?cid=CS-ZC-FT-189499 Sep 09, 2015 - Impax Laboratories (IPXL) received clearance from the FDA for its manufacturing facility at Hayward, CA; shares jumped 12%.
4 Low-Volatility Stocks to Sail Through Market Mayhem http://www.zacks.com/stock/news/189052/4-low-volatility-stocks-to-sail-through-market-mayhem?cid=CS-ZC-FT-189052 Sep 04, 2015 - It has been a topsy-turvy ride for investors so far in 2015.

Pages: 1234567

<Page 2>